Bone loss associated with prevention of breast cancer.
University of Pittsburgh, Pittsburgh, PA, USA. jcauley@edc.pitt.edu
Jane A
JA
Cauley
D000730:Androstadienes / Q000009:adverse effects*; D016588:Anticarcinogenic Agents / Q000009:adverse effects*; D047072:Aromatase Inhibitors / Q000009:adverse effects*; D015519:Bone Density / Q000187:drug effects*; D001842:Bone and Bones / Q000187:drug effects*; D001943:Breast Neoplasms / Q000517:prevention & control*; D005260:Female; D006801:Humans; D010024:Osteoporosis / Q000139:chemically induced*; D017698:Postmenopause; D011322:Primary Prevention / Q000379:methods*
D000730:Androstadienes; D016588:Anticarcinogenic Agents; D047072:Aromatase Inhibitors; C056516:exemestane